JOENSUU, Heikki et al. Outcome of patients with HER2-positive breast cancer treated with or without adjuvant trastuzumab in the Finland Capecitabine Trial (FinXX). Acta Oncologica, [S. l.], v. 53, n. 2, p. 186–194, 2014. DOI: 10.3109/0284186X.2013.820840. Disponível em: https://medicaljournalssweden.se/actaoncologica/article/view/26983. Acesso em: 17 feb. 2025.